drugset / Trial / NCT00419120

Augmentation Cystoplasty Using an Autologous Neo-Bladder

NCT00419120 ↗

Phase 2 Terminated 10 enrolled Tengion
NaSingle-groupOpen-labelTreatment

Summary

Subjects with neurogenic bladder secondary to spina bifida refractory to medical treatment will be enrolled. The hypothesis is that augmentation cystoplasty using an autologous neo-bladder construct will significantly increase bladder compliance.

Timeline

Start
2006-12
Primary completion
2008-10
Completion
2011-04

Outcome

Outcome not reported

Stopped: “36 months follow up without change to profile. No further studies planned.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Autologous neobladder construct Unknown — —

Indications

No indication recorded.